Literature DB >> 15361971

Chagasic meningoencephalitis: case report of a recently included AIDS-defining illness in Brazil.

Geraldine Madalosso1, Alessandra C Guedes Pellini, Marileide J Vasconcelos, Ana Freitas Ribeiro, Leonardo Weissmann, Gilberto Silva Oliveira Filho, Augusto C Penalva de Oliveira, Jose E Vidal.   

Abstract

Recently, reactivation of Chagas disease (meningoencephalitis and/or myocarditis) was included in the list of AIDS-defining illnesses in Brazil. We report a case of a 52-year-old patient with no history of previous disease who presented acute meningoencephalitis. Direct examination of blood and cerebrospinal fluid (CSF) showed Trypanosoma cruzi. CSF culture confirmed the diagnosis. Serological assays for T. cruzi and human immunodeficiency virus (HIV) were positive. Despite treatment with benznidazol and supportive measures, the patient died 24 hours after hospital admission. In endemic areas, reactivation of Chagas disease should always be considered in the differential diagnosis of meningoencephalitis among HIV-infected patients, and its presence is indicative of AIDS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15361971     DOI: 10.1590/s0036-46652004000400005

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  7 in total

1.  The Anti-Trypanosoma cruzi activity of posaconazole in a murine model of acute Chagas' disease is less dependent on gamma interferon than that of benznidazole.

Authors:  Marcela L Ferraz; Ricardo T Gazzinelli; Rosana O Alves; Julio A Urbina; Alvaro J Romanha
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

Review 2.  Importance of nonenteric protozoan infections in immunocompromised people.

Authors:  J L N Barratt; J Harkness; D Marriott; J T Ellis; D Stark
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

3.  CHAGASIC MENINGOENCEPHALITIS IN AN HIV INFECTED PATIENT WITH MODERATE IMMUNOSUPPRESSION: PROLONGED SURVIVAL AND CHALLENGES IN THE HAART ERA.

Authors:  Renata Buccheri; Maria José Kassab; Vera Lucia Teixeira de Freitas; Sheila Cristina Vicente da Silva; Rita C Bezerra; Zarifa Khoury; Maria Aparecida Shikanai-Yasuda; José E Vidal
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015-12       Impact factor: 1.846

Review 4.  Parasitic infections in HIV infected individuals: diagnostic & therapeutic challenges.

Authors:  Veeranoot Nissapatorn; Nongyao Sawangjaroen
Journal:  Indian J Med Res       Date:  2011-12       Impact factor: 2.375

5.  Use of a Chagas Urine Nanoparticle Test (Chunap) to Correlate with Parasitemia Levels in T. cruzi/HIV Co-infected Patients.

Authors:  Yagahira E Castro-Sesquen; Robert H Gilman; Carolina Mejia; Daniel E Clark; Jeong Choi; Melissa J Reimer-McAtee; Rosario Castro; Edward Valencia-Ayala; Jorge Flores; Natalie Bowman; Ricardo Castillo-Neyra; Faustino Torrico; Lance Liotta; Caryn Bern; Alessandra Luchini
Journal:  PLoS Negl Trop Dis       Date:  2016-02-26

Review 6.  Immunosuppression and Chagas disease: a management challenge.

Authors:  María-Jesús Pinazo; Gerard Espinosa; Cristina Cortes-Lletget; Elizabeth de Jesús Posada; Edelweiss Aldasoro; Inés Oliveira; Jose Muñoz; Montserrat Gállego; Joaquim Gascon
Journal:  PLoS Negl Trop Dis       Date:  2013-01-17

Review 7.  Acute chagas disease: new global challenges for an old neglected disease.

Authors:  Daniela V Andrade; Kenneth J Gollob; Walderez O Dutra
Journal:  PLoS Negl Trop Dis       Date:  2014-07-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.